• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Prophylactic therapies to treat septic shock - Tolerance to LPS-induced microvascular change in mouse skin

Research Project

Project/Area Number 13672401
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 応用薬理学・医療系薬学
Research InstitutionTokyo Women's Medical University

Principal Investigator

FUJII Emiko  Tokyo Women's Medical University, School of Medicine, Associate Professor, 医学部, 助教授 (20075493)

Co-Investigator(Kenkyū-buntansha) IRIE Kaoru  Tokyo Women's Medic University, School of Medicine, Instructor, 医学部, 助手 (50075496)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 2002: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2001: ¥1,100,000 (Direct Cost: ¥1,100,000)
Keywordsendotoxin / lipid A analog / vascular permeability / cytokine / nitric oxide (NO) / septic shock / endotoxin tolerance / glucocorticoid / 敗血症性ショック / 誘導型NO合成酵素(iNOS) / iNOS欠損マウス / プロスタグランジン
Research Abstract

Subcutaneous injection of lipopolysaccharide (LPS) increases plasma leakage in mouse skin. Pretreatment with LPS conditions mice tolerant to the LPS-induced plasma leakage. Nitric oxide (NO) has been suggested to be involved in these LPS effects. A specific role of inducible NO synthase (iNOS) was investigated in the LPS-induced plasma leakage using iNOS deficient mice. It has been postulated that most biological activities of LPS are derived from lipid A moiety. We examined the effect of lipid A analog (ONO-4007) in increasing plasma leakage. Subcutaneous injection of LPS in mice that were preinjected I.v. with Pontamine sky blue dye produced a dose-related increase in dye leakage in both iNOS deficient and wild-type mice with about 40% less dye leakage in iNOS deficient mice. The LPS-induced dye leakage was not inhibited by inhibitors of NOS and LPS pretreatment in iNOS deficient mice. These studies indicate that LPS-induced dye leakage is mediated by NO produced by iNOS, prostaglandin (PG), histamine and TNF-α. The tolerance against LPS-induced vascular permeability change may be mediated by iNOS induction. Subcutaneous injection of ONO-4007 induced a dose-dependent increase in dye leakage. In iNOS deficient mice, ONO-4007 increased the dye leakage. A constitutive NOS-derived NO, TNF-α and IL-1α but not PG or histamine play a role in ONO-4007-induced increase in plasma leakage. Although ONO-4007 mimics LPS in increasing vascular permeability, mechanisms of permeability change elicited by ONO-4007 were not identical to those of LPS. ONO-4007 induced transient tolerance to plasma leakage elicited by LPS, ONO-4007 and inflammatory mediators. Endogenous corticosterone, at least in part, plays a role in development of tolerance. The tolerance induced by LPS may provide a potential basis for the treatment of sepsis, lipid A analog may be useful as a prophylactic therapy of septic shock.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Hiroyasu ISHIDA: "Role of inflammatory mediators in lipid A analog (ONO-4007) -induced vascular permeability change in mouse skin"Br. J. Pharmacol.. 130(6). 1235-1240 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Emiko FUJII: "Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide"Br. J. Pharmacol.. 130(1). 90-94 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kaoru IRIE: "Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin"Br. J. Pharmacol.. 133(2). 237-242 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hiroyasu ISHIDA: "A lipid A analog ONO-4007 induces tolerance to plasma leakage in mice"Inflamm. Res.. 51(1). 38-43 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Taiyo SUGANUMA: "Effect of heat stress on lipopolysaccharide-induced vascular permeability change in mice"J. Pharmacol. Exp. Ther.. 303(2). 656-663 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kaoru IRIE: "Anti-inflammatory effect of a Rho kinase inhibitor, Y27632, on the lipopolysaccharide (LPS)-induced increase in vascular permeability in mice"Jpn. J. Pharmacol.. 88 Suppl I. 122 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 入江かをる: "「エンドトキシン研究5 研究と治療の進歩」Rho kinase阻害薬の抗炎症作用"日本エンドトキシン研究会編 医学図書出版、東京. 187 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Keiji WADA, Emiko FUJII, Hiroyasu ISHIDA, Toshimasa YOSHIOKA & Takamura MURAKI: "Effect of lipoteichoic acid on dermal vascular permeability in mice."J. Pharmacol. Exp. Ther.. 294(1). 280-286 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hiroyasu ISHIDA, Emiko FUJII, Kaoru IRIE, Toshimasa YOSHIOKA, Takamura MURAKI & Ryou OGAWA: "Role of inflammatory mediators in lipid A analog (ONO-4007)-induced vascular permeability change in mouse skin."Br. J. Pharmacol.. 130(6). 1235-1240 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kaoru IRIE, Emiko FUJII, Hiroyasu ISHIDA, Keiji WADA, Taiyo SUGANUMA, Tomohiro NISHIKORI, Toshimasa YOSHIOKA & Takamura MURAKI: "Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin."Br. J. Pharmacol.. 133(2). 237-242 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hiroyasu ISHIDA, Kaoru IRIE, Taiyo SUGANUMA, Emiko FUJII, Toshimasa YOSHIOKA, Takamura MURAKI & Ryou OGAWA: "A lipid A analog ONO-4007 induces tolerance to plasma leakage in mice."Inflamm. Res.. 51(1). 38-43 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Taiyo SUGANUMA, Kaoru IRIE, Emiko FUJII, Toshimasa YOSHIOKA & Takamura MURAKI: "Effect of heat stress on lipopolysaccharide-induced vascular permeability change in mice."J. Pharmacol. Exp. Ther.. 303(2). 656-663 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hiroyasu ISHIDA: "Role of inflammatory mediators in lipid A analog (ONO-4007)-induced vascular permeability change in mouse skin"Br. J. Pharmacol. 130(6). 1235-1240 (2000)

    • Related Report
      2002 Annual Research Report
  • [Publications] Emiko FUJII: "Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide"Br. J. Pharmacol. 130(1). 90-94 (2000)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kaoru IRIE: "Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide(LPS)-induced microvascular permeability change in mouse skin"Br. J. Pharmacol. 133(2). 237-242 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hiroyasu ISHIDA: "A lipid A analog ONO-4007 induces tolerance to plasma leakage in mice"Inflamm. Res.. 51(1). 38-43 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Taiyo SUGANUMA: "Effect of heat stress on lipopolysaccharide-induced vascular permeability change in mice"J. Pharmacol. Exp. Ther.. 303(2). 656-663 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kaoru IRIE: "Anti-inflammatory effect of a Rho kinase inhibitor, Y27632, on the lipopolysaccharide(LPS)-induced increase in vascular permeability in mice"Jpn. J. Pharmacol.. 88SupplI. 122 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 入江かをる: "「エンドトキシン研究5 研究と治療の進歩」 Rho kinase阻害薬の抗炎症作用"日本エンドトキシン研究会 編 医学図書出版、東京. 187 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 伊藤景一, 渡辺弘美: "在宅における神経内科疾患患者と家族に対する保健医療福祉サービスの評価に利用しうる多次元的なアウトカム指標の開発に関する基礎的研究"日本在宅ケア学会誌. 5巻・2号. 110-111 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi